Sign in
Explore the registryTrack Mezigdomide's trials

SUCCESSOR-2

A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

MezigdomideOngoingActive not recruitingPhase 3Open NCT05552976 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…